Cargando…
Impact of tuberculosis on mortality among HIV-infected patients receiving antiretroviral therapy in Uganda: a prospective cohort analysis
BACKGROUND: Tuberculosis (TB) disease affects survival among HIV co-infected patients on antiretroviral therapy (ART). Yet, the magnitude of TB disease on mortality is poorly understood. METHODS: Using a prospective cohort of 22,477 adult patients who initiated ART between August 2000 and June 2009...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3716897/ https://www.ncbi.nlm.nih.gov/pubmed/23849301 http://dx.doi.org/10.1186/1742-6405-10-19 |
_version_ | 1782277614570831872 |
---|---|
author | Chu, Rong Mills, Edward J Beyene, Joseph Pullenayegum, Eleanor Bakanda, Celestin Nachega, Jean B Devereaux, P J Thabane, Lehana |
author_facet | Chu, Rong Mills, Edward J Beyene, Joseph Pullenayegum, Eleanor Bakanda, Celestin Nachega, Jean B Devereaux, P J Thabane, Lehana |
author_sort | Chu, Rong |
collection | PubMed |
description | BACKGROUND: Tuberculosis (TB) disease affects survival among HIV co-infected patients on antiretroviral therapy (ART). Yet, the magnitude of TB disease on mortality is poorly understood. METHODS: Using a prospective cohort of 22,477 adult patients who initiated ART between August 2000 and June 2009 in Uganda, we assessed the effect of active pulmonary TB disease at the initiation of ART on all-cause mortality using a Cox proportional hazards model. Propensity score (PS) matching was used to control for potential confounding. Stratification and covariate adjustment for PS and not PS-based multivariable Cox models were also performed. RESULTS: A total of 1,609 (7.52%) patients had active pulmonary TB at the start of ART. TB patients had higher proportions of being male, suffering from AIDS-defining illnesses, having World Health Organization (WHO) disease stage III or IV, and having lower CD4 cell counts at baseline (p < 0.001). The percentages of death during follow-up were 10.47% and 6.38% for patients with and without TB, respectively. The hazard ratio (HR) for mortality comparing TB to non-TB patients using 1,686 PS-matched pairs was 1.37 (95% confidence interval [CI]: 1.08 – 1.75), less marked than the crude estimate (HR = 1.74, 95% CI: 1.49 – 2.04). The other PS-based methods and not PS-based multivariable Cox model produced similar results. CONCLUSIONS: After controlling for important confounding variables, HIV patients who had TB at the initiation of ART in Uganda had an approximate 37% increased hazard of overall mortality relative to non-TB patients. |
format | Online Article Text |
id | pubmed-3716897 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2013 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-37168972013-07-20 Impact of tuberculosis on mortality among HIV-infected patients receiving antiretroviral therapy in Uganda: a prospective cohort analysis Chu, Rong Mills, Edward J Beyene, Joseph Pullenayegum, Eleanor Bakanda, Celestin Nachega, Jean B Devereaux, P J Thabane, Lehana AIDS Res Ther Research BACKGROUND: Tuberculosis (TB) disease affects survival among HIV co-infected patients on antiretroviral therapy (ART). Yet, the magnitude of TB disease on mortality is poorly understood. METHODS: Using a prospective cohort of 22,477 adult patients who initiated ART between August 2000 and June 2009 in Uganda, we assessed the effect of active pulmonary TB disease at the initiation of ART on all-cause mortality using a Cox proportional hazards model. Propensity score (PS) matching was used to control for potential confounding. Stratification and covariate adjustment for PS and not PS-based multivariable Cox models were also performed. RESULTS: A total of 1,609 (7.52%) patients had active pulmonary TB at the start of ART. TB patients had higher proportions of being male, suffering from AIDS-defining illnesses, having World Health Organization (WHO) disease stage III or IV, and having lower CD4 cell counts at baseline (p < 0.001). The percentages of death during follow-up were 10.47% and 6.38% for patients with and without TB, respectively. The hazard ratio (HR) for mortality comparing TB to non-TB patients using 1,686 PS-matched pairs was 1.37 (95% confidence interval [CI]: 1.08 – 1.75), less marked than the crude estimate (HR = 1.74, 95% CI: 1.49 – 2.04). The other PS-based methods and not PS-based multivariable Cox model produced similar results. CONCLUSIONS: After controlling for important confounding variables, HIV patients who had TB at the initiation of ART in Uganda had an approximate 37% increased hazard of overall mortality relative to non-TB patients. BioMed Central 2013-07-13 /pmc/articles/PMC3716897/ /pubmed/23849301 http://dx.doi.org/10.1186/1742-6405-10-19 Text en Copyright © 2013 Chu et al.; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Research Chu, Rong Mills, Edward J Beyene, Joseph Pullenayegum, Eleanor Bakanda, Celestin Nachega, Jean B Devereaux, P J Thabane, Lehana Impact of tuberculosis on mortality among HIV-infected patients receiving antiretroviral therapy in Uganda: a prospective cohort analysis |
title | Impact of tuberculosis on mortality among HIV-infected patients receiving antiretroviral therapy in Uganda: a prospective cohort analysis |
title_full | Impact of tuberculosis on mortality among HIV-infected patients receiving antiretroviral therapy in Uganda: a prospective cohort analysis |
title_fullStr | Impact of tuberculosis on mortality among HIV-infected patients receiving antiretroviral therapy in Uganda: a prospective cohort analysis |
title_full_unstemmed | Impact of tuberculosis on mortality among HIV-infected patients receiving antiretroviral therapy in Uganda: a prospective cohort analysis |
title_short | Impact of tuberculosis on mortality among HIV-infected patients receiving antiretroviral therapy in Uganda: a prospective cohort analysis |
title_sort | impact of tuberculosis on mortality among hiv-infected patients receiving antiretroviral therapy in uganda: a prospective cohort analysis |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3716897/ https://www.ncbi.nlm.nih.gov/pubmed/23849301 http://dx.doi.org/10.1186/1742-6405-10-19 |
work_keys_str_mv | AT churong impactoftuberculosisonmortalityamonghivinfectedpatientsreceivingantiretroviraltherapyinugandaaprospectivecohortanalysis AT millsedwardj impactoftuberculosisonmortalityamonghivinfectedpatientsreceivingantiretroviraltherapyinugandaaprospectivecohortanalysis AT beyenejoseph impactoftuberculosisonmortalityamonghivinfectedpatientsreceivingantiretroviraltherapyinugandaaprospectivecohortanalysis AT pullenayegumeleanor impactoftuberculosisonmortalityamonghivinfectedpatientsreceivingantiretroviraltherapyinugandaaprospectivecohortanalysis AT bakandacelestin impactoftuberculosisonmortalityamonghivinfectedpatientsreceivingantiretroviraltherapyinugandaaprospectivecohortanalysis AT nachegajeanb impactoftuberculosisonmortalityamonghivinfectedpatientsreceivingantiretroviraltherapyinugandaaprospectivecohortanalysis AT devereauxpj impactoftuberculosisonmortalityamonghivinfectedpatientsreceivingantiretroviraltherapyinugandaaprospectivecohortanalysis AT thabanelehana impactoftuberculosisonmortalityamonghivinfectedpatientsreceivingantiretroviraltherapyinugandaaprospectivecohortanalysis |